Da la bienvenida a la Doctora Emily Carter como Nuevo CEO para Liderar la Compañía en la Próxima Fase de Crecimiento

12DNA is pleased to announce the appointment of Dr. Emily Carter as its new Chief Executive Officer. With a distinguished career in genetics research and industry leadership, Dr. Carter brings a wealth of expertise and strategic vision to guide 12DNA towards continued growth and innovation in the field of gene editing and genetic medicine.